Zacks Market Edge Highlights: Tesla, NVIDIA, JPMorgan Chase, Exxon Mobil and Novo Nordisk

For Immediate ReleaseChicago, IL – March 14, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:  https://www.zacks.com/stock/news/2429903/is-a-recession-coming-in-2025-where-to-invest-now)Is a Recession Coming in 2025? Where to Invest NowWelcome to Episode #437 of the Zacks Market Edge Podcast.(1:00) - Are We Heading Towards A Recession?(7:10) - What Can We Expect From The Fed The Next Few Months?(12:30) - How Should You Position Your Portfolio Right Now?(17:40) - Top Stocks To Keep On Your Watchlist(28:30) - Episode Roundup: ABBV, XOM, FANG, JPM, NVDA, TSLA, NVO, LLY, GPC                Podcast@Zacks.comEvery week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.This week, Tracey is joined by John Blank, Zacks Chief Equity Strategist, to discuss what they always discuss every few months on the podcast: is the United States in a recession? And if not, is one coming?With all the market turmoil, they also discuss what investors should do right now. What stocks should investors buy?John is the editor of Zacks Large-Cap Trader portfolio so he had some suggestions about what he was looking at in the large caps. Tracey is the editor of Zacks Value Investor portfolio so she mentions some value stocks.5 Stocks After the Sell-Off: Should They Be On Your Short List?1. Tesla, Inc. TSLATesla is one of the Magnificent 7 stocks. They have all corrected in the sell-off, which means they are down at least 10%. But Tesla is down even more, falling 38.6% year-to-date.Tesla's earnings are expected to rise 23.5% in 2025 and another 25.9% in 2026. Tesla has gotten more attractive on a price-to-earnings (P/E) basis since the shares have sold off. It is now trading at 77x. That is not cheap, however. A P/E under 15 is considered a value.Should Tesla be on your short list after the sell-off?2. NVIDIA Corp. NVDANVIDIA is also one of the Magnificent 7 stocks. Over the last 5 years, shares of NVIDIA are up 2040%. But year-to-date, shares have fallen 13.8%.NVIDIA saw record revenue in fiscal 2025 of $130.5 billion, up 114% year-over-year. NVIDIA's earnings are expected to jump 46.8% in fiscal 2026 and another 24.3% in fiscal 2027.After the stock sell-off, it now has a forward P/E of just 24.8. This is historically low for NVIDIA.Should NVIDIA be on your short list at this valuation?3. JPMorgan Chase & Co. JPMJPMorgan Chase is one of the largest banks in the United States. Over the last year, shares are up 20%. But year-to-date, JPMorgan Chase shares have fallen 4.9%.Earnings of JPMorgan Chase are expected to fall 8.1% in 2025. It now trades with a forward P/E of 12.6. JPMorgan Chase also pays a dividend, which yields 2.2%.Should a big bank like JPMorgan Chase be on your short list?4. Exxon Mobil Corp. XOMExxon Mobil is a large, integrated American energy company. Oil stocks have been weak over the last year as oil prices have tumbled. Exxon Mobil shares are up in the last year, but just 0.8%. In 2025, with all the market turmoil, Exxon Mobil is still up 1.5%.However, earnings are expected to fall 4.9% in 2025. Exxon Mobil has a forward P/E of 14.7. A P/E under 15 usually indicates a stock is a value. Exxon Mobil also pays a dividend, yielding 3.6%.Should energy stocks like Exxon Mobil be on your short list?5. Novo Nordisk A/S NOVNovo Nordisk is a global healthcare company headquartered in Denmark. It specializes in diabetes and weight loss. Shares of Novo Nordisk soared on increased sales of the weight loss drugs, gaining 180% in the last 5 years. But year-to-date, shares have fallen 12.8%.Earnings are expected to rise 17% in 2025 and another 21.3% in 2026. Novo Nordisk now trades with a forward P/E of 20.3. Novo Nordisk also pays a dividend, yielding 0.9%.Should a big healthcare company like Novo Nordisk be on your short list?What Other Stocks Do Tracey and John Talk About After the Sell-Off? Tune into this week's podcast to find out.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Follow us on Twitter:  https://twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch/Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.com/performancePast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Exxon Mobil Corporation (XOM): Free Stock Analysis Report NVIDIA Corporation (NVDA): Free Stock Analysis Report NOV Inc. (NOV): Free Stock Analysis Report Tesla, Inc. (TSLA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks